Home > Insider Trading > Filing (0000899243-16-020304)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1597553	Sage Therapeutics Inc.	SAGE	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1180428	J Mark Levin	29 Newbury Street, 3Rd Floor Boston MA 02116	No	No	Yes	No
1192595	I Robert Tepper	29 Newbury Street, 3Rd Floor Boston MA 02116	No	No	Yes	No
1488495	Third Rock Ventures Ii, L.p.	C/O Third Rock Ventures, Llc 29 Newbury Street, 3Rd Floor Boston MA 02116	No	No	Yes	No
1614061	Third Rock Ventures Gp Ii, L.p.	29 Newbury Street, 3Rd Floor Boston MA 02116	No	No	Yes	No
1614073	Trv Gp Ii, Llc	29 Newbury Street, 3Rd Floor Boston MA 02116	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-05-16	850,000	$31.25	3,892,916	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	65,226	Direct
Common Stock	65,226	Direct

Footnotes

The shares are directly held by Third Rock Ventures II, L.P. ("TRV"). The general partner of TRV is Third Rock Ventures GP II, L.P. ("TRV GP"). The general partner of TRV GP is TRV GP II, LLC ("TRV GP LLC"). The individual managers of TRV GP LLC are Mark Levin, Kevin Starr and Dr. Robert Tepper. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.
The shares are directly hold by Dr. Robert Tepper.
The shares are directly held by Mark Levin.